Analysis of Risk Factors for the Association of Sarcopenia in Patients with Type 2 Diabetes Mellitus
DOI: https://doi.org/10.2147/dmso.s446894
2024-03-27
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Yijun Du, 1, 2, &ast Yue Wang, 1, 2, &ast Ping Zhang, 1, 2 Xing Zhong, 1, 2 Tianrong Pan 1, 2 1 Department of Endocrinology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, People's Republic of China; 2 Research Center for Translational Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, People's Republic of China &astThese authors contributed equally to this work Correspondence: Tianrong Pan, Department of Endocrinology, The Second Affiliated Hospital of Anhui Medical University, No. 678 Furong Road, Jingkai District, Hefei, 230601, People's Republic of China, Email Background: Previous studies have shown that the prevalence of sarcopenia in patients with type 2 diabetes mellitus (T2DM) has increased significantly over the years. However, the risk factors for the association of sarcopenia in patients with T2DM are unknown. Therefore, we attempted to investigate the risk factors through measurement and analysis of the patients' data from April 2020 to April 2022. Methods: A total of 334 hospitalized patients with T2DM were divided into sarcopenia group (n=101) and non-sarcopenia group (n=233). Clinical factors were compared between the two groups and also between the two genders. Receiver operating characteristic curve (ROC) was used to analyze the ROC diagnostic ability of related factors in sarcopenia. Results: (1) Among the 334 patients, the overall prevalence of sarcopenia was 30.2%; 41.3% in men and 20.1% in women. (2) The multifactorial logistic regression analysis showed that gender (specifically for men; OR=4.997, 95% CI: 2.611– 9.564), low body mass index (BMI) (OR=1.525, 95% CI: 1.353– 1.718), lower 25(OH)D levels (OR=1.076, 95% CI:1.036– 1.117), and lower IGF-1 (OR=1.013, 95% CI:1.006– 1.020) were independent risk factors (P < 0.05). (3) ROC curve analysis results showed that BMI, 25 (OH) D, IGF-1, and testosterone (for men) had predictive significance for sarcopenia with T2DM (P < 0.05). However, the AUC of 25 (OH) D, IGF-1 and testosterone (for men) were all 0.7, has great predictive significance. Conclusion: The prevalence of sarcopenia in hospitalized patients with T2DM is higher in men than in women. Low BMI and lower serum levels of 25 (OH) D and IGF-1 are risk factors of sarcopenia in patients with T2DM. Low BMI, 25(OH)D, IGF-1, and testosterone (for men) all contributed to the prediction of sarcopenia, among which BMI and combined factors were more significant. Keywords: risk factors, sarcopenia, T2DM, body mass index, 25 (OH) D, IGF-1 Two common old age-related diseases in the Chinese population are type 2 diabetes mellitus (T2DM) and sarcopenia, which is a degenerative disease characterized by the loss of skeletal muscle function and mass. 1 Skeletal muscle accounts for 40% of the body's total weight and is an important part of the motor system as almost all of the body's activities are controlled by the contraction of the skeletal muscles. In addition, skeletal muscle is one of the major utilizers of glucose in the body and is the largest insulin-sensitive tissue, due to which it plays a very important role in energy and metabolic homeostasis. 2 Therefore, the skeletal muscle plays an important role in T2DM. People with T2DM are at high risk for developing sarcopenia, and the prevalence of sarcopenia in T2DM patients is much higher than that in the normal population. 3 Findings from the Asian Working Group for Sarcopenia (AWGS) showed a prevalence of 15% in Chinese (>60 years) and Japanese (≥65 years) adults with T2DM. 4 Diabetes and sarcopenia interact with each other. The disorder of glucose metabolism promotes the catabolism of the body and the breakdown of muscle protein, thus leading to the decline of muscle function and muscle content. 5 The decrease of muscle content will further aggravate insulin resistance, and the insulin resistance of muscle will inhibit the energy metabolism of muscle cell mitochondria and affect the normal contraction function of muscle tissue. 6 At the same time, the elderly are prone to unbalanced nutritional intake and insufficient protein intake, and inappropriate diabetes diet control will further increase the risk of malnutrition, resulting in a significant decline in muscle mass and strength. As a chronic metabolic disorder, T2DM greatly impacts the quality of life of a patient; for patients with T2DM who also develop sarcopenia, the risks of developing disabilities, falling and fracturing bone -Abstract Truncated-
endocrinology & metabolism